BLTE files Rule 144 to sell 10,000 ADS

BLTE submitted a notice under Rule 144 proposing the sale of 10,000 American Depositary Shares (each representing one ordinary share).

Rhea-AI Filing Summary

BLTE submitted a notice under Rule 144 proposing the sale of 10,000 American Depositary Shares (each representing one ordinary share). The shares are described as Vested RSUs with a vesting date of 10/17/2025. The filing date shown is 06/16/2026.

Insights

Securities Attorney

Rule 144 notice for sale of vested RSUs; procedural disclosure.

The filing lists 10,000 American Depositary Shares as proposed for sale and identifies them as Vested RSUs with a vesting date of 10/17/2025. This is a routine disclosure that notifies the market of intended resale under securities resale rules.

Timing and proceeds treatment are not detailed in the excerpt; subsequent filings or trade reports would show whether and when the shares were actually sold.

Key Figures

Shares proposed for sale: 10,000 shares Vesting date: 10/17/2025 Filing date: 06/16/2026

3 metrics

Shares proposed for sale 10,000 shares American Depositary Shares to be sold

Vesting date 10/17/2025 Vested RSUs vesting date

Filing date 06/16/2026 Form 144 filing date shown

Key Terms

American Depositary Shares, Vested RSUs, Rule 144

3 terms

American Depositary Shares financial

"American Depositary Shares, each representing one ordinary share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Vested RSUs financial

"Vested RSUs | Issuer | 10000 | 10/17/2025"

Rule 144 regulatory

"Filer Information | 144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BLTE's Form 144 disclose?

The Form 144 discloses a proposed sale of 10,000 American Depositary Shares, identified as vested RSUs, with a vesting date of 10/17/2025 and a filing date of 06/16/2026. It is a regulatory notice of intent to sell.

Are the shares in BLTE's filing already vested?

Yes. The filing specifically lists the securities as Vested RSUs with a vesting date of 10/17/2025. That indicates the underlying awards had vested on that date.

How many BLTE shares are proposed for sale in the Form 144?

The Form 144 shows a proposed sale of 10,000 American Depositary Shares (each representing one ordinary share). The filing lists this quantity as the securities to be sold.

Does BLTE's Form 144 state who will receive the sale proceeds?

The excerpt does not specify proceeds treatment or the recipient. The filing identifies the securities as Issuer source type but does not state detailed cash‑flow recipients in the provided lines.

Which broker‑dealer is listed in BLTE's Form 144?

The excerpt lists J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, NY, as a broker/dealer associated with the transaction details shown in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 07:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002113223
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Belite Bio, Inc.
SEC File Number	001-41359
Address of Issuer	12750 High Bluff Drive Suite 475 San Diego CALIFORNIA 92130
Phone	858-246-6240
Name of Person for Whose Account the Securities are To Be Sold	Dr. Hendrick P. Scholl
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares, each representing one ordinary share	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	10000	1442400	39339960	06/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares, each representing one ordinary share	10/17/2025	Vested RSUs	Issuer			10000	10/17/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This shares represented on this filing form are being sold by Bioptima Ltd., Dr. Hendrick P. Scholl as Director
Date of Notice	06/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Dr. Hendrik P. Scholl
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)